0000899243-23-008783.txt : 20230316
0000899243-23-008783.hdr.sgml : 20230316
20230316202707
ACCESSION NUMBER: 0000899243-23-008783
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230314
FILED AS OF DATE: 20230316
DATE AS OF CHANGE: 20230316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rao Srinivas
CENTRAL INDEX KEY: 0001860902
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40493
FILM NUMBER: 23740459
MAIL ADDRESS:
STREET 1: C/O ATAI LIFE SCIENCES N.V.
STREET 2: 180 VARICK STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATAI Life Sciences N.V.
CENTRAL INDEX KEY: 0001840904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: WALLSTRASSE 16
CITY: BERLIN
STATE: 2M
ZIP: 10179
BUSINESS PHONE: (617)-699-5876
MAIL ADDRESS:
STREET 1: 524 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: ATAI Life Sciences B.V.
DATE OF NAME CHANGE: 20210115
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-14
0
0001840904
ATAI Life Sciences N.V.
ATAI
0001860902
Rao Srinivas
WALLSTRASSE 16
BERLIN
2M
10179
GERMANY
0
1
0
0
See Remarks
Stock Option
1.18
2023-03-14
4
A
0
600000
0.00
A
2033-03-14
Common Shares
600000
600000
D
Restricted Stock Unit
2023-03-14
4
A
0
350000
0.00
A
Common Shares
350000
350000
D
The stock option shall vest as to 25% of the underlying shares on March 14, 2024, and in 36 substantially equal monthly installments thereafter.
Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.
Co-Founder and Chief Scientific Officer
/s/ Ryan Barrett, Attorney-in-fact
2023-03-16